Oxford Asset Management’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-19,155	Closed	-$170K	–	1941
2019 Q3	$170K	Sell	19,155 -7,454	-28%	-$81.7K	﹤0.01%	1591
2019 Q2	$380K	Buy	26,609 +12,823	+93%	+$342K	0.01%	1376
2019 Q1	$453K	Sell	13,786 -10,583	-43%	-$543K	0.01%	1262
2018 Q4	$1.45M	Buy	24,369 +2,503	+11%	+$247K	0.04%	663
2018 Q3	$3.07M	Buy	21,866 +9,190	+72%	+$1.12M	0.06%	424
2018 Q2	$1.48M	Sell	12,676 -2,657	-17%	-$226K	0.03%	840
2018 Q1	$1.37M	Buy	15,333 +3,159	+26%	+$268K	0.03%	779
2017 Q4	$679K	Sell	12,174 -2,085	-15%	-$94K	0.01%	1088
2017 Q3	$585K	Buy	14,259 +5,616	+65%	+$234K	0.01%	1143
2017 Q2	$364K	Buy	+8,643	New	+$442K	0.01%	1199
2016 Q2	–	Sell	-2,049	Closed	-$164K	–	846
2016 Q1	$164K	Sell	2,049 -17,648	-90%	-$1.39M	﹤0.01%	726
2015 Q4	$1.5M	Buy	+19,697	New	+$3.16M	0.04%	450